Search

Displaying results 2721 - 2730 of 10000 in total
  1. Indication

    Not amenable to radiotherapy Nasopharyngeal Carcinoma (NPC)

    go.drugbank.com/conditions/DBCOND0173493
    Drugs: Tislelizumab
    Synonyms: Not amenable to radiotherapy Nasopharyngeal Carcinoma (NPC)
  2. Indication

    Refractory Indolent B-Cell Non-Hodgkin Lymphoma

    go.drugbank.com/conditions/DBCOND0165948
    Drugs: Bendamustine
    Synonyms: Refractory Indolent B-Cell Non-Hodgkin Lymphoma, Refractory indolent B cell non-hodgkin lymphoma
  3. Indication

    Metastatic untreated non small cell lung cancer

    go.drugbank.com/conditions/DBCOND0025493
    Drugs: Docetaxel
    Synonyms: Metastatic untreated non small cell lung cancer, Metastatic Untreated Non-Small Cell Lung Cancer
  4. Indication

    Refractory Low Grade Non-Hodgkin's Lymphoma (NHL)

    go.drugbank.com/conditions/DBCOND0145177
    Drugs: Rituximab
    Synonyms: Refractory Low Grade Non-Hodgkin's Lymphoma (NHL)
  5. Indication

    Refractory follicular B-cell non-Hodgkin's lymphoma

    go.drugbank.com/conditions/DBCOND0108696
    Drugs: Rituximab
    Synonyms: Refractory follicular B-cell non-Hodgkin's lymphoma
  6. Indication

    Unresectable Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0166223
    Drugs: Trastuzumab deruxtecan · Zenocutuzumab
    Synonyms: Unresectable Non-Small Cell Lung Cancer (NSCLC)
  7. Drug

    Acrivastine

    go.drugbank.com/drugs/DB09488
    Approved

    As an H1 receptor antagonist, it functions by blocking the action of histamine at this receptor thereby preventing the symptoms associated with histamine release such as pruritis, vasodilation, hypotension … Acrivastine is a triprolidine analog antihistamine indicated for the treatment of allergies and hay fever.

    Categories: Histamine H1 Antagonists, Non-Sedating
  8. Drug

    Cladribine

    go.drugbank.com/drugs/DB00242
    ApprovedInvestigational

    Cladribine is a purine analogue or a chlorinated derivative of adenine that causes apoptosis of B and T lymphocytes. Cladribine was first approved in the United States in 1993 initially as a treatment for a number of hematological malign...

  9. Drug

    ARCT-810

    go.drugbank.com/drugs/DB17683
    Investigational

    ARCT-810 is an mRNA replacement therapy that delivers ornithine transcarbamylase mRNA to hepatocytes.

  10. Drug

    Flucytosine

    go.drugbank.com/drugs/DB01099
    ApprovedInvestigational

    A fluorinated cytosine analog that is used as an antifungal agent.